ArticleScience (New York, N.Y.)2026

Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy.

Yun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.